In support of the functional consequences of these human tumor findings, an unbiased RNAi-based forward genetic screen also identified PLK2 as one of the candidate tumor suppressors in breast cancer (Fig. 1E; refs. 37, 38). The gene discussed is PLK2; the disease is neoplasm.